Global Breast Imaging Technology Market Overview:
Breast Imaging Technology market is expected to grow in the future due to technological advancements and the rising prevalence of breast cancer. Increasing demand for breast cancer screening and improving reimbursement scenarios are expected to boost the market in the forecasted period. The 3-D tomosynthesis segment is identified as the fastest-growing segment in the breast imaging market. The use of AI in breast imaging technology is trending in the market.
- Rising Prevalence of Breast Cancer
- Increasing Number of Conferences and Symposiums Focusing on Spreading Awareness about the Benefits of Early Screening and Diagnosis
- Technological Advancements in Breast Imaging such as Molecular Breast Imaging, Digital Mammogram
- Use of AI in Breast Imaging Technology
- The High Cost of Breast Imaging System
- Stringent Regulatory Approval Procedures
- Improvement in Reimbursement Scenario in the Healthcare Industry in Developing Region
- Emerging Economies Offer High Growth Potential in the Market
- Increasing Adoption of Refurbished Imaging Systems
Some of the key players profiled in the report are Hologic, Inc. (United States), GE Healthcare (United States), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (United States), Allengers (India), Dilon Technologies, Inc. (United States), Planmed Oy (Finland) and Delphinus Medical Technologies, Inc.(United States). Additionally, following companies can also be profiled that are part of our coverage like Micrima Limited (United Kingom), CMR Naviscan Corporation (United States), SuperSonic Imagine (France) and Carestream Health (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Breast Imaging Technology market by 2025.
In Nov 2014, Hologic gets approval from FDA for AI-based breast imaging technology. The newly approved technology, called 3DQuorum Imaging Technology, powered by Genius AI, builds on that underlying system by modifying the reconstruction step.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Breast Imaging Technology market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Breast Imaging Technology market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Breast Imaging Technology Provider, Healthcare Industry, Potential Investors, Technology Investors, Research Firm and Government Agencies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.